Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 920-926

  Menashe, Ofir ^a   Kaganskaya, Elena ^a   Baasov, Timor ^a   Yaron, Sima ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; TOBRAMYCIN;

ACIDITY; ANIMAL CELL; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; PH; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SEROTYPE;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; CATION TRANSPORT PROTEINS; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; SALMONELLA TYPHIMURIUM; SEROTYPING;

EID: 40549133793     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00382-07     Document Type: Article

References (42)

1. Abromaitis, S., S. Faucher, M. Beland, R. Curtiss III, and F. Daigle. 2005. The presence of the tet gene from cloning vectors impairs Salmonella survival in macrophages. FEMS Microbiol. Lett. 242:305-312.
2. Barcia-Macay, M., C. Seral, M. P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke. 2006. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50:841-851.
3. Bonventre, P. F., R. Hayes, and J. Imhoff. 1967. Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J. Bacteriol. 93:445-450.
4. Bottger, E. C., B. Springer, T. Prammananan, Y. Kidan, and P. Sander. 2001. Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. 2:318-323.
5. Bowen, H., T. E. Biggs, E. Phillips, S. T. Baker, V. H. Perry, D. A. Mann, and C. H. Barton. 2002. c-Myc represses and Miz-1 activates the murine natural resistance-associated protein 1 promoter. J. Biol. Chem. 277:34997-35006.
6. Carlier, M. B., G. Laurent, P. J. Claes, H. J. Vanderhaeghe, and P. M. Tulkens. 1983. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies. Antimicrob. Agents Chemother. 23:440-449.
7. Chan, K., C. C. Kim, and S. Falkow. 2005. Microarray-based detection of Salmonella enterica serovar Typhimurium transposon mutants that cannot survive in macrophages and mice. Infect. Immun. 73:5438-5449.
8. Craig, J. E., A. Cliffe, K. Garnett, and N. J. High. 2001. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol. Lett. 203:55-61.
9. E, is required for intracellular survival of nontypeable Haemophilus influenzae in J774 macrophages. Infect. Immun. 70:708-715.
10. Drevets, D. A., B. P. Canono, P. J. Leenen, and P. A. Campbell. 1994. Gentamicin kills intracellular Listeria monocytogenes. Infect. Immun. 62:2222-2228.
11. Eisenberg, E. S., L. J. Mandel, H. R. Kaback, and M. H. Miller. 1984. Quantitative association between electrical potential across the cytoplasmatic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J. Bacteriol. 157:863-867.
12. Eustice, D. C., and J. M. Wilhelm. 1984. Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics. Biochemistry 23:1462-1467.
13. Francis, K. P., and M. P. Gallagher. 1993. Light emission from a Mudlux transcriptional fusion in Salmonella typhimurium is stimulated by hydrogen peroxide and by interaction with the mouse macrophage cell line 1774.2. Infect. Immun. 61:640-649.
14. Govoni, G., F. Canonne-Hergaux, C. G. Pfeifer, S. L. Marcus, S. D. Mills, D. J. Hackam, S. Grinstein, D. Malo, B. B. Finlay, and P. Gros. 1999. Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7. Infect. Immun. 67:2225-2232.
15. Hackam, D. J., O. D. Rotstein, W. Zhang, S. Gruenheid, P. Gros, and S. Grinstein. 1998. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J. Exp. Med. 188:351-364.
16. Henderson, S. C., D. I. Bounous, and M. D. Lee. 1999. Early events in the pathogenesis of avian salmonellosis. Infect. Immun. 67:3580-3586.
17. Johnson, J. D., W. L. Hand, J. B. Francis, N. King-Thompson, and R. W. Corwin. 1980. Antibiotic uptake by alveolar macrophages. J. Lab. Clin. Med. 95:429-439.
18. Kihlstrom, E., and L. Andaker. 1985. Inability of gentamicin and fosfomycin to eliminate intracellular Enterobacteriaceae. J. Antimicrob. Chemother. 15:723-728.
19. Lee, C. K., A. L. Roberts, T. M. Finn, S. Knapp, and J. J. Mekalanos. 1990. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations. Infect. Immun. 58:2516-2522.
20. Le Pocher, H., P. Brouqui, and D. Raoult. 1998. Killing kinetics of intracellular Afipia felis treated with amikacin. J. Antimicrob. Chemother. 42:825-829.
21. Lissner, C. R., R. N. Swanson, and A. D. O'Brien. 1983. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006-3013.
22. Magnet, S., and J. S. Blanchard. 2005. Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105:477-498.
23. Martin-Orozco, N., N. Touret, M. L. Zaharik, E. Park, R. Kopelman, S. Miller, B. B. Finlay, P. Gros, and S. Grinstein. 2006. Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. Mol. Biol. Cell 17:498-510.
24. Maurin, M., and D. Raoult. 1994. Phagolysosomal alkalinization and intracellular killing of Staphylococcus aureus by amikacin. J. Infect. Dis. 169:330-336.
25. Maurin, M., and D. Raoult. 2001. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob. Agents Chemother. 45:2977-2986.
26. Myrdal, S. E., K. C. Johnson, and P. S. Steyger. 2005. Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear Res. 204:156-169.
27. Pan, Q., X.-L. Zhang, H.-Y. Wu, P.-W. He, F. Wang, M.-S. Zhang, J.-M. Hu, B. Xia, and J. Wu. 2005. Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar Typhi. Antimicrob. Agents Chemother. 49:4052-4060.
28. Parsons, D. A., and F. Heffron. 2005. sciS, an icmF homolog in Salmonella enterica serovar Typhimurium, limits intracellular replication and decreases virulence. Infect. Immun. 73:4338-4345.
29. Rathman, M., L. P. Barker, and S. Falkow. 1997. The unique trafficking pattern of Salmonella typhimurium-containing phagosomes in murine macrophages is independent of the mechanism of bacterial entry. Infect. Immun. 65:1475-1485.
30. Rathman, M., M. D. Sjaastad, and S. Falkow. 1996. Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect. Immun. 64:2765-2773.
31. Sandoval, R. M., and B. A. Molitoris. 2004. Gentamicin traffics retrograde through the secretory pathway and is released in the cytosol via the endoplasmic reticulum. Am. J. Physiol. Renal Physiol. 286:F617-F624.
32. Schaeffer, L. M., and A. A. Weiss. 2001. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infect. Immun. 69:7635-7641.
33. Seral, C., F. Van Bambeke, and P. M. Tulkens. 2003. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob. Agents Chemother. 47:2283-2292.
34. Taber, H. W., J. P. Mueller, P. F. Miller, and A. S. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439-457.
35. Takaya, A., T. Tomoyasu, H. Matsui, and T. Yamamoto. 2004. The DnaK/DnaJ chaperone machinery of Salmonella enterica serovar Typhimurium is essential for invasion of epithelial cells and survival within macrophages, leading to systemic infection. Infect. Immun. 72:1364-1373.
36. Ulitzur, S., and J. Kuhn. 1988. The transcription of bacterial luminescence is regulated by sigma 32. J. Biolumin. Chemilumin. 2:81-93.
37. Ulitzur, S., A. Matin, C. Fraley, and E. Meighen. 1997. H-NS protein represses transcription of the lux systems of Vibrio fischeri and other luminous bacteria cloned into Escherichia coli. Curr. Microbiol. 35:336-342.
38. Unge, A., R. Tombolini, L. Molbak, and J. K. Janssen. 1999. Simultaneous monitoring of cell number and metabolic activity of specific bacterial populations with a dual gfp-luxAB marker system. Appl. Environ Microbiol. 65:813-821.
39. Vakulenko, S. B., and S. Mobashery. 2003. Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16:430-450.
40. Weinberger, M., H. Solnik-Isaac, D. Shachar, A. Reisfeld, L. Valinsky, N. Andorn, V. Agmon, R. Yishai, R. Bassal, A. Fraser, S. Yaron, and D. Cohen. 2006. Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel. Clin. Microbiol. Infect. 12:999-1005.
41. Wilhelm, J. M., J. J. Jessop, and S. E. Pettitt. 1978. Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells. Biochemistry 17:1149-1153.
42. Xiong, Y. Q., J. Caillou, H. Drugeon, G. Potel, and D. Baron. 1996. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob. Agents Chemother. 40:35-39.